Global Aujeszky Disease Vaccines Market Size By Type (Injection, Freeze-Dried Tablet), By Application (Boar, Piggy), By Geographic Scope And Forecast

Aujeszky Disease Vaccines Market Size And Forecast

Aujeszky Disease Vaccines Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2028.

Vaccinations have become more popular in recent years, owing to an increase in the prevalence of both viral and bacterial infectious diseases. Vaccinations are essentially administered to strengthen the immune system throughout the lifetime and offer protection against different types of infectious diseases. In the coming years, the global Aujeszky Disease Vaccines Market is expected to be driven by increased investment in the development of new vaccines. The Global Aujeszky Disease Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Aujeszky Disease Vaccines Market Definition

Aujeszky disease, also known as pseudorabies, is a viral disease that is endemic in most parts of the world. Suid herpesvirus 1 is to blame (SuHV-1). In areas where classical swine fever (hog cholera) has been eradicated, the Aujeszky disease is regarded as the most economically important viral disease of swine. Other mammals that are susceptible include cattle, sheep, goats, cats, dogs, and raccoons. In these animal species, the disease is usually fatal.

The virus is shed in the saliva and nasal secretions of infected swine via the respiratory route. The virus may also be aerosolized and transmitted by fomites. The virus can survive for up to seven hours in humid air, seven hours in well water, two days in green grass, soil, and fecal matter, three days in contaminated feed, and four days in straw bedding. Although there is no specific treatment for acute SuHV-1 infection, vaccination can alleviate clinical signs in pigs of certain ages.

Global Aujeszky Disease Vaccines Market Overview

The Aujeszky Disease Vaccines Market is expanding rapidly as a result of medical technological advancements such as genetically engineered vaccines against ADV. The outbreak of zoonotic and livestock diseases has aided in the growth of the Aujeszky Disease Vaccines Market. The contribution of governments and non-governmental organizations to the funding of research & development studies is another critical factor. Furthermore, the surge in vaccine demand is another factor imposing an optimistic outlook on the market. However, the lack of awareness among welfare organizations, as well as the implementation of stringent dosage compliance, are expected to stymie market growth.

Moreover, Limited coverage for vaccination coupled with prohibitive costs related to transportation and storage of vaccines will negatively impact the industry expansion to a certain extent in the near future. Nonetheless, the market is witnessing certain growth opportunities such as increasing government initiatives to promote R&D to tackle the rising prevalence of infectious diseases. Furthermore, the market is expected to grow because of the rising livestock population owing to the increasing adoption of animal husbandry as a prime occupation.

Global Aujeszky Disease Vaccines MarketSegmentation Analysis

The Global Aujeszky Disease Vaccines Market is Segmented on the basis of Type, Application, And Geography.

Aujeszky Disease Vaccines Market, By Type

• Injection Aujeszky Disease Vaccines
• Freeze-dried Tablet Aujeszky Disease Vaccines

Based on Type, the market is classified into Injection Aujeszky Disease Vaccines and Freeze-dried Tablet Aujeszky Disease Vaccines. Injection accounted for the highest market share and is anticipated to dominate the market during the forecast period. Rapid and uniform absorption of the drug and rapid onset of the action compared to that of the oral and subcutaneous routes are making it a popular choice.

Aujeszky Disease Vaccines Market, By Application

• Boar
• Piggy
• Sow

Based on Application, the market is divided into Boar, Piggy, and Sow. The market is anticipated to grow due to the focus of animal associations to maintain animal health, and the rising demand for animal-derived food products need to keep animals disease-free is driving the growth of this market.

Aujeszky Disease Vaccines Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of regional analysis, the Global Aujeszky Disease Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the highest market share in the Global Aujeszky Disease Vaccines Market. Along with the high prevalence of infectious diseases and increased investments in vaccine development by governments and non-governmental organizations. Rising production of veterinary products and improved animal husbandry practices are propelling the growth of the market in the region. Whereas the Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period due to increasing awareness, rising disposable income, and government initiatives that are driving the growth of the Asia Pacific market.

Key Players

The “Global Aujeszky Disease Vaccines Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are IDEXX, Ceva, MSD Animal Health, Kyoritsu Seiyaku Corporation, CAVAC, HIPRA, and Zendal group.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Product Launches and Product Expansions

• Aoril’s newest needle-free, intradermal delivery device, IDAL 3G for the IDAL family of products for swine vaccination and the IDAL Way, an extended vaccine portfolio designed for intradermal use, were announced by MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., the USA.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.